drugset / Trial / NCT04851860

Effect of Sublingual Immunotherapy on Platlet factor4 Level in Children

NCT04851860 ↗

Phase 3 Unknown 30 enrolled Zagazig University
NaSingle-groupOpen-labelTreatment

Summary

Better management and improving outcome of children with allergic rhinitis

Timeline

Start
2021-04-12
Primary completion
2021-10-15
Completion
2021-11-20

Drugs

EvaluationDrugModalityDoseRoute
Subject House dust mite allergen extract Unknown — Other

Indications